It targets genes and is essential for controlling synaptic plasticity, such as NRGN and CACNA1C, which are involved in neural development and synaptic function, contributing to the neurodevelopmental hypothesis of schizophrenia. The gene discussed is NRGN; the disease is schizophrenia.